Farr Miller & Washington’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Farr Miller & Washington's BIO Position: Q3 2021 in Review
Farr Miller & Washington increased its Bio-Rad Laboratories Class A (BIO) stake by 8.6% in Q3 2021, buying an estimated $200K and bringing the position to 3,364 shares worth $2.51M. The position accounts for 0.16% of the portfolio, ranked #62.
Farr Miller & Washington first reported a position in BIO in Q1 2017 and has held it in 19 quarters since. 507 funds tracked by Wall St. Rank hold BIO as of Q3 2021.
- Farr Miller & Washington held 3,364 shares of Bio-Rad Laboratories Class A worth $2.51M as of Q3 2021.
- Farr Miller & Washington bought 267 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $200K.
- Bio-Rad Laboratories Class A made up 0.16% of Farr Miller & Washington's portfolio in Q3 2021, its #62 holding.
- Farr Miller & Washington first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and has held it in 19 quarters since.
- 507 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.